Testing and monitoring underway in suspected Russia plague death - UN News
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
HealthThe death of a lab worker in Russia’s Siberia region has sparked concerns over a possible plague case, the UN World Health Organization (WHO) said on Tuesday, adding that it was following the situation closely.
“A woman who worked at the laboratory in Irkutsk oblast has died, and the authorities are looking into whether pneumonic plague caused her death,” WHO spokesperson Christian Lindmeier told reporters in Geneva. He underscored that her workplace was “an institute that studies dangerous pathogens, including plague, in a part of Siberia where plague occurs naturally in wild animals.” Highly contagiousPlague is caused by the bacteria Yersinia pestis usually found in small mammals and their fleas. Pneumonic plague occurs when the bacteria infect the lungs. WHO notes that this form of plague infection is especially contagious and “can trigger severe epidemics through person-to-person transmission via respiratory particles”. According to WHO, pneumonic plague “can be fatal within 18 to 24 hours of disease onset if left untreated, but common antibiotics for enterobacteria can effectively cure the disease if they are delivered early”.
This article is an excerpt. To read the full content, visit the original source. UN News
Related articles
European Medical Journal | HIV linked to early signs of heart dysfunction - European AIDS Treatment Group
Patient-centered financial navigation assistance helps reduce financial toxicity among cancer patients - Medical Xpress
Among cancer patients, the high financial cost of cancer care is a prevalent problem. This financial burden is also associated with potentially harmful behavioral strategies that patients might use to cope with costs, such as delaying or forgoing treatment and skipping medications. Collectively, researchers refer to this impact as financial toxicity.
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!